Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2005 Apr;24(2):140S-145S.
doi: 10.1080/07315724.2005.10719455.

Role of protein and amino acids in the pathophysiology and treatment of sarcopenia

Affiliations
Review

Role of protein and amino acids in the pathophysiology and treatment of sarcopenia

Hans C Dreyer et al. J Am Coll Nutr. 2005 Apr.

Abstract

Sarcopenia, the loss of skeletal muscle mass and function with aging, is a multifactorial condition that slowly develops over decades and becomes a significant contributor to disability in the older population. Malnutrition and alterations in the muscle anabolic response to nutritional stimuli have been identified as potentially preventable factors that may significantly contribute to sarcopenia. Thus, nutritional interventions may be useful for the prevention and treatment of sarcopenia.

PubMed Disclaimer

Figures

Fig. 1
Fig. 1
Effect of an oral essential amino acid bolus on net muscle phenylalanine balance, an index of net muscle protein anabolism.
Fig. 2
Fig. 2
Effects of continuous oral administration of balanced amino acids alone or combined with glucose in young and older adults. *p < 0.01 vs. basal. **p < 0.05 vs. others during feeding.

Similar articles

Cited by

References

    1. Lamberts SW, van den Beld AW, van der Lely AJ. The endocrinology of aging. Science. 1997;278:419–424. - PubMed
    1. Evans WJ. What is sarcopenia? J Gerontol A Biol Sci Med Sci. 1995;50:5–8. Spec No. - PubMed
    1. Morley JE, Baumgartner RN, Roubenoff R, Mayer J, Nair KS. Sarcopenia. J Lab Clin Med. 2001;137:231–243. - PubMed
    1. Roubenoff R, Castaneda C. Sarcopenia-understanding the dynamics of aging muscle. JAMA. 2001;286:1230–1231. - PubMed
    1. Vandervoot AA, Symons TB. Functional and metabolic consequences of sarcopenia. Can J Appl Physiol. 2001;26:90–101. - PubMed

Publication types

Substances